SCHEMBL18947795

SCHEMBL18947795

CC(C)(C)OC(=O)N[C@H]1CC1c1ccc(Br)nc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.59
MAOB P27338 3/20 0.53
MAOA P21397 2/20 0.53
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TLR2 O60603 1/20 0.37
TLR1 Q15399 1/20 0.37
F2R P25116 1/20 0.36
PDE4B Q07343 2/20 0.36
SYK P43405 1/20 0.36
CKS1B P61024 1/20 0.35
SKP1 P63208 1/20 0.35
SKP2 Q13309 1/20 0.35
EPHX2 P34913 1/20 0.35
JAK1 P23458 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14885516 1.00 KDM1A (0.59) KDM1AMAOBMAOANFKB1NFKB2
SCHEMBL28682928 1.00 KDM1A (0.59) KDM1AMAOBMAOANFKB1NFKB2
SCHEMBL3872075 1.00 KDM1A (0.59) KDM1AMAOBMAOANFKB1NFKB2
SCHEMBL16021081 0.88 KDM1A (0.67) KDM1AMAOBMAOACKS1BSKP1
SCHEMBL15094433 0.83 KDM1A (0.70) KDM1AMAOBMAOANFKB1NFKB2
SCHEMBL12242261 0.83 KDM1A (0.70) KDM1AMAOBMAOANFKB1NFKB2
SCHEMBL15149989 0.83 KDM1A (0.70) KDM1AMAOBMAOANFKB1NFKB2
SCHEMBL2212928 0.83 KDM1A (0.70) KDM1AMAOBMAOANFKB1NFKB2
SCHEMBL2564604 0.80 KDM1A (0.70) KDM1AMAOBMAOANFKB1NFKB2
SCHEMBL17287408 0.80 KDM1A (0.70) KDM1AMAOBMAOANFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495349-B1 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS ORYZON GENOMICS SA (ES) 2023-06-28 EP disclosed
EP-3736265-A1 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS Oryzon Genomics, S.A. (ES) 2020-11-11 EP disclosed
EP-2768805-B1 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS ORYZON GENOMICS SA (ES) 2020-03-25 EP disclosed
US-9676701-B2 Cyclopropylamine derivatives useful as LSD1 inhibitors ORYZON GENOMICS, S.A. (ES) 2017-06-13 US disclosed
US-9676701-B2 Cyclopropylamine derivatives useful as LSD1 inhibitors ORYZON GENOMICS, S.A. (ES) 2017-06-13 US disclosed